Citadel Advisors
PYPD icon

Citadel Advisors’s PolyPid PYPD Stock Holding History

Citadel Advisors’s Portfolio PYPD Stock Details PYPD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$253K Buy
57,769
+47,046
+439% +$208K ﹤0.01% 10881
2025
Q4 		$46.5K Buy
+10,723
New +$39.8K ﹤0.01% 12066
2025
Q3 		– Sell
-13,151
Closed -$46.4K – 13833
2025
Q2 		$46.4K Buy
13,151
+2,593
+25% +$7.59K ﹤0.01% 11807
2025
Q1 		$28.6K Buy
+10,558
New +$31.5K ﹤0.01% 12865
2023
Q1 		– Sell
-18
Closed -$384 – 15344
2022
Q4 		$384 Sell
18
-388
-96% -$10K ﹤0.01% 14679
2022
Q3 		$14K Sell
406
-470
-54% -$58.1K ﹤0.01% 12179
2022
Q2 		$122K Sell
876
-267
-23% -$40K ﹤0.01% 11193
2022
Q1 		$187K Buy
1,143
+736
+181% +$111K ﹤0.01% 11619
2021
Q4 		$70K Buy
+407
New +$85.9K ﹤0.01% 13030
2021
Q1 		– Sell
-629
Closed -$188K – 13614
2020
Q4 		$188K Buy
+629
New +$200K ﹤0.01% 9786
2020
Q3 		– Sell
-3,048
Closed -$1.65M – 10606
2020
Q2 		$1.65M Buy
+3,048
New +$1.71M ﹤0.01% 4907

Other funds holding PYPD

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors's PYPD Position: Q1 2026 in Review

Citadel Advisors increased its PolyPid (PYPD) stake by 439% in Q1 2026, buying an estimated $208K and bringing the position to 57,769 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #10881.

Citadel Advisors first reported a position in PYPD in Q2 2020 and has held it in 11 quarters since. The position peaked at $1.65M in Q2 2020. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.

  • Citadel Advisors held 57,769 shares of PolyPid worth $253K as of Q1 2026.
  • Citadel Advisors bought 47,046 PolyPid shares in Q1 2026, an estimated $208K.
  • PolyPid made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10881 holding.
  • Citadel Advisors first reported a position in PolyPid in Q2 2020 and has held it in 11 quarters since.
  • Citadel Advisors's PolyPid position peaked at $1.65M in Q2 2020.
  • 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.